- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04091659
Use of Virtual Reality for Overdose Management Educational Trainings
December 1, 2020 updated by: Nicholas Giordano, PhD, RN, University of Pennsylvania
This cluster-randomized trial will compare changes in attitudes and knowledge on administering naloxone based on exposure to either a virtual reality educational training or the current standard educational trainings (e.g.
on-line videos, printed information handouts) offered at local libraries.
Individuals attending local library's naloxone training days will voluntarily complete an anonymous validated survey pre and post attending either the virtual reality or standard educational training.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study will utilize a cluster-randomized trial design.
Entire libraries will be randomized to either offer community members the virtual reality training or the standard educational offerings (e.g.
handouts, online videos).
Volunteers will be asked to complete the brief, anonymous, and validated Opioid Overdose Knowledge Scale prior to receiving an education intervention (pretest) and then again immediately after (posttest).
Neither participants nor investigators will be blinded.
Library patrons who do not participate in the study will be offered current standard training materials.
Regardless of the library's randomization, to either virtual reality or standard training, all patrons completing pre and post test surveys will have the opportunity to view the virtual reality training or other public health department materials.
Study Type
Interventional
Enrollment (Actual)
98
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able to complete paper surveys independently
- Provide verbal consent
Exclusion Criteria:
- Unable to complete immediate post-training assessment
- Individuals under 18 years of age
- Individuals who cannot communicate in English and provide consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard Education
Standard Educational (Control): The public health department's training includes printed handouts on how to administer naloxone and youtube videos on how to spot signs and symptoms of overdose and administer naloxone.
Additionally, staff are on hand to provide one on one verbal educational trainings to local community members voluntarily seeking education.
|
Standard Educational (Control): The public health department's training includes printed handouts on how to administer naloxone and youtube videos on how to spot signs and symptoms of overdose and administer naloxone.
Additionally, staff are on hand to provide one on one verbal educational trainings to local community members voluntarily seeking education.
|
Experimental: Virtual Reality
Virtual Reality Education (Intervention): The experimental group of libraries will receive the virtual reality simulation, which is guided by the NLN Jeffries Simulation Theory, and lasts 9 minutes.
The virtual reality education is based on scenes and dialogue conducted during the hybrid high-fidelity simulation, from a script developed using the existing hybrid simulation on opioid overdose intervention.
This virtual reality education is an educational intervention.
|
Virtual Reality Education (Intervention): The experimental group of libraries will receive the virtual reality simulation, which is guided by the NLN Jeffries Simulation Theory, and lasts 9 minutes.
The virtual reality education is based on scenes and dialogue conducted during the hybrid high-fidelity simulation, from a script developed using the existing hybrid simulation on opioid overdose intervention.
This virtual reality education is an educational intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Opioid Overdose Knowledge Scale (OOKS) From Pre- to Post-training
Time Frame: Immediately Pre-Training and Within 1 Hour Post-training
|
Higher scores on the OOKS indicate greater knowledge on how to identify and appropriately intervene during an opioid related overdose, including proper use of naloxone.
The tool has been validated with healthcare professionals and lay persons and used to assess changes in knowledge and attitudes after in-person naloxone trainings.
This main outcome of this study is examining changes in the OOKS subscale for signs of an opioid overdose with scores ranging from 0 to 10.
|
Immediately Pre-Training and Within 1 Hour Post-training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Opioid Overdose Attitudes Scale (OOAS) From Pre- to Post-training
Time Frame: Immediately Pre-Training and Within 1 Hour Post-training
|
The OOAS subscales assessing competencies to manage an opioid overdose (5 items).
Study participants were given intranasal naloxone, so all items were adapted to refer to intranasal naloxone rather than injectable naloxone.
OOAS items were scored on a Likert-type scale and higher scores suggested more favorable attitudes towards opioid overdose response, where 1=completely disagree, and 5=completely agree
|
Immediately Pre-Training and Within 1 Hour Post-training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nicholas A Giordano, lecturer
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 18, 2019
Primary Completion (Actual)
January 15, 2020
Study Completion (Actual)
January 16, 2020
Study Registration Dates
First Submitted
September 11, 2019
First Submitted That Met QC Criteria
September 12, 2019
First Posted (Actual)
September 17, 2019
Study Record Updates
Last Update Posted (Actual)
December 22, 2020
Last Update Submitted That Met QC Criteria
December 1, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 833978
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All collected IPD will be made available upon request with approved IRB from requesting institution
IPD Sharing Time Frame
1 year after study completion and up to 3 years later
IPD Sharing Access Criteria
Made available upon request and with approved IRB from requesting institution
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Virtual Reality
-
Palo Alto UniversityCompleted
-
The Opole University of TechnologyCompleted
-
Shenandoah UniversityCompletedVirtual RealityUnited States
-
The Opole University of TechnologyIRCCS San Camillo, Venezia, ItalyCompleted
-
The Methodist Hospital Research InstituteNational Institute on Aging (NIA)CompletedVirtual RealityUnited States
-
Seoul National University Bundang HospitalCompleted
-
Hacettepe UniversityCompleted
-
Sunnybrook Health Sciences CentreNot yet recruiting
-
Medical University of LodzNational Center for Research and Development, Poland; Senopi AGRecruiting
Clinical Trials on Standard Education
-
McGill UniversityMcMaster University; University of Sydney; Institut National du Sport du QuebecRecruiting
-
Hospital Israelita Albert EinsteinNot yet recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1
-
Northumbria UniversityNewcastle-upon-Tyne Hospitals NHS TrustRecruitingSarcopenia | Coronary Heart Disease | Low Protein IntakeUnited Kingdom
-
Rajavithi HospitalCompleted
-
University of OklahomaRecruitingObesity | Bariatric Surgery Candidate | Endometrial CancerUnited States
-
Ohio State UniversityFoundation for Physical Therapy, Inc.CompletedPain | Hip Injuries | Therapy/RehabilitationUnited States
-
University Hospitals of North Midlands NHS TrustRecruitingAsthma | Asthma in ChildrenUnited Kingdom
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); Canadian Center for Vaccinology and other collaboratorsCompleted
-
University Hospital, MontpellierCompleted
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionCompleted